Nailya Bulatova

Scopus Publications

Behind the counter, behind the discourse: The paradox of pharmacist influence in Arabic women's health online
Samar J. Melhem, Hamzeh Almomani, Rimal Mousa, Qais Alefan, Nadia Al Mazrouei, Beisan A. Mohammad, Iman Amrani, Rula M. Darwish, Razan Tubeileh, Yazan AlRashadan, Nailya Bulatova, Ibrahim Alabbadi
Exploratory Research in Clinical and Social Pharmacy, 2026
Background: Social media is now a major arena for Arabic women's health discourse in the MENA region, yet it is unclear how pharmacists' expertise influences both the accuracy and visibility of information across platforms. Objective: To compare pharmacists' visibility and accuracy with other author groups and to assess how platform, sentiment, and follower dynamics shape the gap between information quality and reach. Methods: We conducted a cross-sectional content analysis of 682 public Arabic-language posts on women's self-medication and over-the-counter care from Instagram, YouTube, TikTok, Threads, Facebook, and X (January 2024-March 2025). Two independent coders rated accuracy on a four-point scale and classified sentiment (κ > 0.80). Engagement was summarized using the Virtual Presence Index (VPI), an equally weighted composite of standardized likes, comments, and shares/reposts. Proportional-odds ordinal logistic regression modeled predictors of higher accuracy; a non-circular binary logistic model examined determinants of high engagement (above-median VPI) with platform, author type, sentiment, topic, and linear plus quadratic log₁₀(follower count) as covariates. Results: Pharmacists authored 49.6 % of posts; physicians and other health professionals contributed 37.1 %. Overall, 71.8 % of posts were rated accurate, rising to 94.1 % for pharmacist-authored content. Platform was the strongest predictor of accuracy: compared with Instagram, Facebook, YouTube, Threads, and X had higher odds of higher accuracy, with TikTok showing a smaller but significant advantage. Pharmacist authorship independently predicted higher accuracy, whereas follower count did not. For engagement, platform dominated. With X as the reference, all other platforms had lower adjusted odds of high VPI. Positive sentiment increased the likelihood of high VPI, and follower count showed a U-shaped association, with mid-sized accounts disadvantaged. After adjustment, author-type differences in visibility were modest: pharmacists' posts were more accurate but did not enjoy consistent visibility advantages, especially on highly visual, fast-scroll platforms. Conclusion: In Arabic women's health discourse online, who speaks matters less for reach than where and how they speak. Pharmacists deliver the most accurate content but often remain "invisible experts" in environments that reward aesthetics and emotion over credentials. The VPI helps quantify this quality-reach gap and can guide platform-specific, culturally attuned strategies to make evidence-based voices more discoverable.
Functional Molecular Plasma Biomarkers of Inflammation and Repair in Kidney Disease Progression in Gum Arabica Modality of CKD
Sameeha AlShelleh, Maysa Suyagh, Hussein Alhawari, Nailya Bulatova, Violet Kasabri, Ayman Wahbeh, Izzat Alawwa, Ashraf Oweis, Haneen Mustafa
International Journal of Molecular Sciences, 2026
Using colorimetric ELISA, this study aims to assess the impact of Gum Arabica (GA) consumption on functional molecular plasma biomarkers of chronic kidney disease (CKD) via a prospective cohort of GA-consumers (cases) vs. non-consumer (age- and CKD stage-matched) controls. Cohort’s hypertension (92.5%), dyslipidemia (64.8%), and diabetes mellitus (54.8%) were prevalent; the mean CKD duration was 6.94 years (SD 7.8) for both study groups. Comparable eGFR, sCr, ESR, CRP, HbA1c, FPG, UA, and fasting lipid parameters were in both study arms. In consumer cases, the mean duration of GA-consumption was 1.3 ± 1.1 (range 0.25–6) years with a mean dose of 1.7 ± 1.0 (range 0.5–6) spoons per day. Leucine-rich alpha 2-glycoprotein, plasminogen activator inhibitor 1, sirtuin 1, and SOST–sclerostin 1 were significantly (p value < 0.01) of lower concentrations, but lipocalin 2 and uromodulin were invariably (p value < 0.05) greater in the GA-consumer cases than those of controls. Strikingly, cystatin C, myeloperoxidase, orosomucoid 1, and symmetric dimethylarginine lacked any substantial variations in the GA-consumer cases vs. those in controls (p value > 0.05). Proportional correlations of CKD duration–PAI1 levels and sCr-lipocalin 2 levels but inverse correlations of orosomucoid 1-hypertension duration and SDMA-DBP were evident in cases.
Integrating metabolomics into obesity care: towards biomarker-guided pharmacy practice
Ahmed M Almehdi, Fatima M Al Daffaie, Basma M Sharaf, Adnane Guella, Nelson C Soares, Hamza M Al Hroub, Waseem El Huneidi, Mohammad AY Alqudah, Ahmad Y Abuhelwa, Karem H Alzoubi, Eman Abu Gharbieh, Violet Kasabri, Nailya R Bulatova, Bashaer Abu Irmaileh, Yasser Bustanji, Mohammad H Semreen
Pharmacy Practice, 2026
Background: Obesity is a complex and prevalent global health issue strongly associated with chronic diseases. Early diagnosis and precise monitoring remain challenging due to the complex metabolic dysregulation underlying obesity. Metabolomics provides a powerful tool to investigate biochemical changes and discover novel diagnostic biomarkers. Objectives: This study used untargeted metabolomics of human plasma samples to identify distinct plasma metabolite profiles and altered metabolic pathways in overweight and obese individuals. The ultimate goal is to improve obesity management through early diagnosis and personalized treatments. Methods: A total of 74 Jordanian participants were recruited and categorized into normal-weight (n=29), overweight (n=17), and obese (n=28) groups based on BMI and metabolic parameters. Plasma samples were analyzed using ultra-high-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight mass spectrometry (UHPLC-ESI-QTOF-MS). Data processing and statistical analysis were performed using MetaboScape and MetaboAnalyst 5.0. Group comparisons were evaluated using t-tests, ANOVA, and multivariate models, and pathway enrichment analysis was conducted to determine altered metabolic pathways. Results: A total of 82 metabolites were identified, with 26 showing significant differences between groups. In the overweight group, pantothenic acid and L-proline were elevated, while phenylacetaldehyde and glycerophosphocholine were decreased. The obese group exhibited increased levels of L-leucine, L-tryptophan, phenylalanine, and tyrosine, and reduced levels of 2,3-diaminopropionic acid and phenylacetaldehyde. Key altered pathways included pantothenate and CoA biosynthesis, beta-alanine metabolism, phenylalanine and tyrosine metabolism, and beta-oxidation of long-chain fatty acids. Conclusions: The study revealed significant novel metabolic disturbances associated with overweight and obesity, highlighting potential diagnostic biomarkers and perturbed metabolic pathways. These findings provide valuable insights into the molecular underpinnings of obesity, underscore the potential of metabolomics in advancing personalized approaches for managing obesity, and warrant further validation in larger, diverse populations to assess their diagnostic and clinical relevance.
Enhancing Clinical Decision-Making in Gestational Diabetes Through Metabolomics: A Pharmacy Practice Outlook
Rimas Taher Tokatly, Basma M. Sharaf, Ahmad Y. Abuhelwa, Sameh S. M. Soliman, Waseem El Huneidi, et al.
Pharmacy Practice, 2026
Gestational diabetes mellitus (GDM) is a pregnancy complication associated with glucose intolerance and an increased risk of type 2 diabetes. Metabolic alterations, including changes in amino acids, fatty acids, and glycolysis, have been linked to GDM. However, comprehensive metabolomics analyses, particularly in Middle Eastern women cohort, are lacking. This study aims to identify unique metabolic pathways to enhance understanding of disease progression and guide diagnosis and targeted therapeutic strategies. Blood samples were collected from 32 women with GDM and 21 healthy pregnant women. Metabolomic analysis was performed using trapped ion mobility spectrometry time-of-flight mass spectrometry. Statistical analysis included a two-tailed independent Student’s t-test, with a significance threshold of p < 0.05. Out of 108 identified metabolites student’s t-test analysis revealed 33 statistically significant metabolites (P < 0.05) in GDM group compared to healthy pregnant women. Of them, citramalic acid, creatinine, D-arginine, and glutamine were significantly reduced in GDM, while 4-aminohippuric acid, homovanillic acid, alpha-aspartyl-lysine, L-aspartyl-L-phenylalanine, L-valine, L-leucine, and normetanephrine were increased. Pathway analysis further highlighted phenylacetate metabolism as a key pathway upregulated in GDM. This underscores the potential significance of phenylacetate metabolism in the metabolic alterations associated with GDM. A comprehensive understanding of metabolic alteration in GDM provides valuable insights into the factors influencing the metabolic environment of pregnant women with GDM. This knowledge not only enhances our understanding of the molecular mechanisms underlying GDM but also paves away for developing diagnostic and targeted therapeutic strategies. By addressing dysregulated metabolomic pathways, these findings hold the potential for improving the management and prevention of GDM.
Combinatorial multiplicity of cardiometabolic and inflammatory markers in gum arabica modality of CKD CAM: Part 2
Sameeha Alshelleh, Maysa Suyagh, Hussein Alhawari, NAILYA BULATOVA, VIOLET KASABRI, Ayman Wahbeh, Izzat Alawwa, Ashraf Oweis, Haneen Mustafa
Pharmacy Practice, 2025
AIM: A combinatorial multiplicity of molecular blood markers were assessed using ELISA colorimetric determinations in this prospective cohort study of the impact of guar gum arabica (GA) use on kidney function parameters of chronic kidney disease (CKD) in consumers (cases) vs. non consumers (age- and CKD stage- matched controls). RESULTS: Mean age of study participants was 68.12 (±SD 10) years with homogenous sex distribution in both study arms and comparable levels of eGFR, sCr, ESR, CRP, HbA1c, FPG, UA and fasting lipid profiling parameters (P value >0.05). Consistently in study population of recruits; mean CKD duration was 6.94 years (±SD 7.8) and CKD stage IV (37.6% of total study population) was of predominant incidence, followed by stages IIIa and IIIb (20.4% and 19.4%, respectively). Despite the negative glucosuria in 75% of CKD patients; hypertension (92.5%), dyslipidemia (64.8%) and diabetes mellitus (54.8%) were prevalent in a descending order of predominance. GA consumption mean duration was 1.3±1.1 (range 0.25-6) years with a mean dose of 1.7±1.0 (range 0.5-6) spoons per day. Substantially plasma concentrations of resistin (P value =0.047), and nesfatin-1 in cases were substantially greater (P value =0.005) but obestatin (P value =0.018), kisspeptin (P value =0.006), and vascular endothelial growth factor (VEGF) (P value =0.003) were found of pronouncedly lower blood levels in cases in comparison to those of controls. Invariably, human asymmetric dimethylarginine (ADMA), zinc alpha 2-glycoprtein, alpha klotho, ghrelin, and C-reactive protein (CRP) lacked any significant discrepancies in plasma levels in cases vs. those of controls (P value >0.05). In CKD cases on GA modality, ghrelin had substantial inverse correlations with dialysis duration, FBS and uric acid in CKD cases. Pronounced proportional associations of sCr levels were found with ghrelin, hsCRP and resistin in the same pool of cases. eGFR disproportionally correlated with cases’ hsCRP and resistin. In GA-naïve-CKD controls; sCr related proportionally and significantly with asymmetric dimethylarginine (ADMA) and Zinc alpha 2-glycoprtein. CONCLUSIVELY: interventional studies are much justifiably needed.
Scaling holistic e-health solutions in cancer care using a qualitative realist framework
Samar J. Melhem, Shereen Nabhani-Gebara, Nailya Bulatova, Ibrahim Alabbadi, Hamzeh Almomani, Rimal Mousa, Ahmed Almousa, Yazan AlRashdan, Omar Nimri, Reem Kayyali
Frontiers in Public Health, 2025
Background While e-health innovations have advanced cancer-care delivery in high-income countries, middle-income countries (MICs) face distinct systemic, infrastructural, and sociocultural challenges in adopting and scaling digital-health interventions. There is a growing imperative to explore how holistic digital platforms can be implemented effectively in oncology within resource-constrained settings. Objective This study aimed to investigate the barriers and facilitators influencing the scalability and adoption of a comprehensive e-health solution in cancer care, drawing on a realist paradigm to determine what works, for whom, and under which circumstances, in the context of Jordan. Methods A qualitative study, underpinned by a realist paradigm, was conducted using in-depth, semi-structured interviews with oncology healthcare professionals from diverse clinical settings in Jordan. Interviews were conducted in Arabic, translated into English, and analyzed using a hybrid inductive–deductive framework approach. The Implementation of Change Model guided interpretation of the findings, enabling the identification of multi-level contextual influences. Results The analysis yielded a central theme— Facilitators and Barriers to Implementing a Holistic e-health Solution —comprising six deductive subthemes derived from the Implementation of Change Model: (A) Innovation; (B) Patients; (C) Healthcare professionals; (D) Organizational context; (E) Social context; and (F) Economic and political context. Across these subthemes, interpretive codes were classified as barriers or facilitators. Participants emphasized the necessity of assessing e-health readiness prior to implementation, and the importance of integrated, cross-sectoral approaches to support scalable, sustainable solutions. Conclusion This study provides novel, contextually grounded insights into the implementation dynamics of digital transformation in oncology within MICs. It offers actionable guidance for policymakers and system designers aiming to foster sustainable, equitable digital-health ecosystems.
The relationship of selected biomarkers of gut microbiota dysbiosis with adiposity and metabolic risk factors in nascent metabolic syndrome patients
Maysa Suyagh, Violet Kasabri, Nailya Bulatova, Sumaya Abuloha, Jameel Al-Bzour, et al.
Pharmacy Practice, 2024
Background: This study aimed to compare and correlate between non-diabetic MetS, newly diagnosed drug naive pre-diabetic MetS patients vs. lean, apparently healthy and normoglycemic controls the plasma levels of cardiometabolic risk biomarkers’ of pharmacotherapy (appraised using colorimetric and chromatography assays of gut dysbiosis carnitine, choline, γbutyrobetaine, TMAO, Zonulin, survivin, Leukocyte cell-derived chemotaxin 2 (LECT2) and antioxidative stressors (catalase, superoxide dismutase (SOD) and Trolox total antioxidative capacity), adiposity, and atherogenicity with non-insulin based surrogate insulin resistance (sIR) indices. Methods: ANOVA comparisons and Spearman’s rank correlations were conducted in this cross-sectional study of 30 normoglycemic lean subjects (control), 30 nonprediabetic MetS subjects and 30 MetS/pre-diabetic (PreDM) enrolled. Results: MetS-PreDM group presented significantly higher values of FPG (P2<0.001,P3 =0.009) and A1C (P values <0.001) than both normoglycemic MetS and control groups. However, MetS-PreDM and normoglycemic MetS recruits had appreciably higher values of DBP, SBP, TG, and non-HDL-C but significantly lower values of HDL-C (P values <0.001) than the controls. Explicitly no significance in variance was noticeable among any of the study arms (P value < 0.05) for any of the hematological indices. Nevertheless, Both MetS groups (nonprediabetic and PreDM) had substantially higher values for each of adiposity, atherogenecity and surrogate insulin resistance (non insulin based) indices (P2<0.001) vs. controls’ respectively. Both Survivin and LECT2 levels were significantly higher in PreDM MetS group (P value < 0.05 vs. nondiabetic MetS participants). Conversely all 5 gut dysbiosis biomarkers (carnitinine, choline, γBB, TMAo and Zonulin) which proved significantly lower vs. those of either controls (nondiabetic lean or MetS). Surprisingly, a significant variation in all tested 7 biomarkers’ plasma levels were found between nondiabetic MetS and PreDM-MetS groups (P3 < 0.05). Interestingly all 3 antioxidative stressors were on the decline as anticipated; where catalase, SOD % inhibitions and trolox total antioxidative capacities were significantly lower in both MetS recruits vs. controls. Importantly the discrepancy between normoglycemic nonprediabetic MetS vs. the MetS-PreDM (P3 < 0.05) may have not ranked up to significance in indices, clinical parameters or biomarkers. Notably in pooled MetS (both normoglycemic and pre-diabetics participants (N =60)). Most exquisitely survivin with dysbiosis choline and γBB correlated positively and pronouncedly with carnitine in pooled MetS participants. Also in a striking similarity, cardiometabolic LECT2 has a marked direct relation with each of dyasbiosis carnitine and γBB. TMAO, nevertheless, related inversely and significantly with all 3 dysbiosis biomarkers, likewise Zonulin associated disproportionally with both choline and γBB. Exceptionally TMAO- TYG and Zonulin-TYG-WHpR paired in substantial and inverse relations in pooled normoglycemic and preDM MetS participants (n=60). To superbly signify the anticipated deterioration in metabolism via gut microbiota-insulin insensitivity interconnectivity; all dysbiosis biomarkers (carnitine, choline, γBB, TMAO, Zonulin and survivin) correlated highly remarkably and proportionally with all non insulin based surrogate insulin resistance indices in 60 MetS recruits (both normoglycemic and prediabetic; equally). Unequivocally γBB associated directly and pronouncedly with almost all adiposity indices. Surprisingly VAI correlated negatively with Zonulin in the same MetS population. FBG associated exceptionally with carnitine and γButyrobetaine (γBB). Substantially A1c correlated proportionally (P values <0.05) with MetS pooled cases dysbiosis’ carnitine, choline, γBB, and cardiometabolic surviving. Outstandingly both SBP and DBP had direct and marked linkage to LECT2 and so did DBP with choline’s plasma levels. Remarkably TMAO related negatively and pronouncedly with MetS cases levels of FBG, A1c, TG, LDL-C, and so did also zonulin with both A1c and LDL-C. Conclusions: Given the intergroup discrepancies in dysbiosis and cardiometabolic biomarkers along with their elective correlations with MetS-related indices and clinical parameters; our study cannot rule out any potentiality in molecular crosstalk and interplay of those biomarekers with the pathophysiology of MetS and preDM with their related dysregularities. Carnitine, choline, γbutyrobetaine, TMAO, Zonulin, survivin, and LECT2 can be putatively surrogate biomarkers to use as prognostic/predictive tools for the diagnosis/prevention and potential targets for MetS treatment.
Correlation of Plasma and Salivary Osteocalcin Levels with Nascent Metabolic Syndrome Components with and Without Pre/Diabetes Biochemical Parameters
Pharmacy Practice, 2024
Differential changes in maternal proinflammatory IL6 plasma levels as a putatively surrogate marker of candidacy and clinical utility during mid-and late pregnancy hyperglycemia: interventional impact of clinical pharmacist on maternal and neonatal outcomes in a randomized clinical trial
Pharmacy Practice, 2024
Results of Preclinical Studies of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1,2,4-triazole-4-th Bromide in Relation to the Hemostasis System in vivo
Y. Wang, N. R. Bulatova, E. E. Klen, G. A. Rozit, I. L. Nikitina, E. A. Smolyarchuk, K. A. Zavadich, I. D. Krylova, A. V. Samorodov
Drug Development and Registration, 2024
Introduction. A characteristic manifestation of vascular brain damage is depressive disorders that accompany both acute and chronic disorders of cerebral circulation. Depression not only reduces the patient's quality of life, but also complicates the treatment of basic vascular disease, increases the risk of stroke and death. Therefore, complex therapy of vascular depression includes not only antidepressants, but also basic means to correct the consequences of disorders of cerebral blood flow, including with antiplatelet activity. In this regard, the development of a new molecule based on thietane-containing heterocycles, combining the properties of an antidepressant and an antiplatelet agent.Aim. To conduct a preclinical evaluation of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1,2,4-triazol-4 bromide when administered to rats.Materials and methods. A study was conducted of the effect of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietan-3-yl)-1H-1,2,4-triazol-4-bromide on the hemostasis system during intravenous and intragastric administration to healthy white non-linear sexually mature male rats (n = 160). Thromboelastography was performed on a TEG 5000 device, activated with a 0.2 M solution of calcium chloride, Born aggregometry and standard clotting tests to assess the coagulation component of hemostasis.Result and discussion. The findings show that 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1,2,4-triazole-4-th bromide with peroral administration exceeded acetylsalicylic acid by 2.8 times in terms of ED50, and by 1.8 times with intravenous way of administration accordingly. A similar effect of pentoxifylline in the intravenous route of administration was recorded at a concentration of 27.8 mg/kg versus 12.4 mg/kg of compound I. The results of a complex method to assess the state of the hemostasis system indicate a more pronounced antiaggregational effect of compound I compared with pentoxifylline and acetylsalicylic acid.Conclusion. Preclinical studies of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1,2,4-triazole-4 bromide, was demonstrated that a combination of antidepressant and antiplatelet activity, which can serve as a basis for further drug development.
Alteration in the expression of the chemotherapy resistance-related genes in response to chronic and acute hypoxia in pancreatic cancer
Malek Zihlif, Tareq Hameduh, Nailya Bulatova, Hana Hammad
Biomedical Reports, 2023
Plasma carnitine, choline, γ-butyrobetaine, and trimethylamine-N-oxide, but not zonulin, are reduced in overweight/obese patients with pre/diabetes or impaired glycemia
Alia Snouper, Violet Kasabri, Nailya Bulatova, Maysa Suyagh, Monther Sadder, Khaldoun Shnewer, Ismail Yousef
International Journal of Diabetes in Developing Countries, 2023
A Cross-sectional Study of the Catalase Genetic Polymorphism (-262 cytosine/ thymine) and Blood Catalase Activity among Jordanian Vitiligo Patients
Ebtesam Alhawamdeh, Nailya R. Bulatova, Al Motassem F. Yousef, Mohammed A. AlAbbadi, Ethar A. Omer
Jordan Journal of Pharmaceutical Sciences, 2023
The Effect of Antipsychotics and Their Combinations with Other Psychotropic Drugs on Electrocardiogram Intervals Other Than QTc among Jordanian Adult Outpatients
Nailya Bulatova, Noor Altaher, Radwan BaniMustafa, Akram Al-Saleh, Haya Yasin, Mohammed Zawiah, Hala Khalefah, Mokhtar Ghilan, Ala’a Al-Lahham, Mohummad Hudaib, Batoul AlKhawaldeh, Mahmoud Nasr
Biomedicines, 2023
Use of traditional and complementary medicine for COVID 19 prophylaxis among healthcare professionals and students in Jordan: A cross-sectional study
Nailya Bulatova, Sara Younes, Majd Arabiyat, Ahmad Abukaff, Sara Madanat, Eman Alqudah, Anoud Hamati, Farah Halawa, Abdallah Younes
Plos One, 2022
Serotonin reuptake inhibitors effect on fluconazole activity against resistant Candida glabrata strains
Bashar A. Alkhalifa, Nailya R. Bulatova, Waed abuRokba, Rula M. Darwish
Journal of Global Antimicrobial Resistance, 2022
Identification of Insulin Resistance Biomarkers in Metabolic Syndrome Detected by UHPLC-ESI-QTOF-MS
Leen Oyoun Alsoud, Nelson C. Soares, Hamza M. Al-Hroub, Muath Mousa, Violet Kasabri, Nailya Bulatova, Maysa Suyagh, Karem H. Alzoubi, Waseem El-Huneidi, Bashaer Abu-Irmaileh, Yasser Bustanji, Mohammad H. Semreen
Metabolites, 2022
Painful subacute thyroiditis occurring after the administration of influenza vaccine and hyaluronic acid dermal filler
Nailya R. Bulatova, Ayman A. Zayed, Ula Qasem Hijjawi, Satani G. Sharkas, Faris G. Bakri
Medicine United States, 2022
Silver nanoparticles, a promising treatment against clinically important fluconazole-resistant Candida glabrata
R.M. Darwish, M.Y. AlKawareek, N.R. Bulatova, A.M. Alkilany
Letters in Applied Microbiology, 2021
Characterization of staphylococci sampled from diabetic foot ulcer of Jordanian patients
A.G. Al‐Bakri, N.R. Bulatova, N.A. Younes, G. Othman, D. Jaber, N. Schleimer, A. Kriegeskorte, K. Becker
Journal of Applied Microbiology, 2021
Pharmaceutical Care in the Treatment of Substance Use Disorders in Jordan: A Randomized Controlled Trial
Haya Yasin, Nailya Bulatova, Mayyada Wazaify
Substance Use and Misuse, 2021
The effect of psychotropic medications and their combinations on the QTC interval among jordanian outpatients: A cross-sectional study
Nailya Bulatova, , Noor Altaher, Radwan A. BaniMustafa, Akram Al-Saleh, Haya Yasin, Mohammad Zawiah, Hala M. Khalefah, Sara Younes, Ala'a Joul Al-Lahham, Mohummad I. Hudaib, Mokhtar A. Ghilan, Batool AlKhawaldeh, Adel Ali Twaissi, , , , , , , , , , , , and
Anadolu Psikiyatri Dergisi, 2021
Patterns of Substance Use among Patients in Addiction Rehabilitation in Jordan.
Haya Yasin, Nailya Bulatova, Mayyada Wazaify
Substance Use and Misuse, 2020
Patterns and perceived efficacy of herbal medicine for weight loss and maintenance: A cross-sectional survey from Jordan
Amal Akour, Violet Kasabri, Nailya Bulatova, Suha Al Muhaissen, Ruba Al Tarawneh, Bayan Al-Anati, Noor Alhourani
European Journal of Integrative Medicine, 2020
A pre-post study of vitamin d supplement effects on urinary megalin: The emerging predictive role of megalin in diabetic nephropathy progression
Violet Kasabri, Amal Akour, Nailya Bulatova, Maysa Suyagh, Al Motassem Yousef, Hussein Al Hawari, Sameeha Al Shelleh, Jameel Bzour, Hiba Fahmawi
Endocrine Metabolic and Immune Disorders Drug Targets, 2020
The effect of an innovative psychiatry clerkship on pharmacy students perceptions towards mental health and stigma: A pilot intervention study from Jordan
Jordan Journal of Pharmaceutical Sciences, 2019
Correlates of ghrelin and visfatin in metabolic syndrome patients with and without prediabetes
Heba Salah Abushahla, Nailya Bulatova, Violet Kasabri, Randa Naffa
International Journal of Diabetes in Developing Countries, 2019
Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes
Rawan AbuZayed, Nailya Bulatova, Violet Kasabri, Maysa Suyagh, Lana Halaseh, Sundus AlAlawi
Hormone Molecular Biology and Clinical Investigation, 2019
Assessment of inappropriate medication use in Jordanian elderly hospitalized patients using 2015 beers criteria
Nailya BULATOVA, Eman ELAYEH, Shayma ABDULLAH, Lana HALASEH
Turk Geriatri Dergisi, 2019
Urinary megalin in association with progression factors of diabetic nephropathy
A. Akour, V. Kasabri, N. Bulatova, Y. Al-Motassem, H. Fahmawi, M. Momani, A. Zayed, R. Alquoqa, H. AlHawari
Bratislava Medical Journal, 2019
Correlations of oxytocin, fibroblast growth factor-21 and hepatocyte growth factor in diabetic and non-diabetic metabolic syndrome patients: Acase- control study from Jordan
Jordan Journal of Pharmaceutical Sciences, 2019
Increased malondialdehyde vs. reduced sirtuin 1 in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes
Samar Abu Rkhaya, Nailya Bulatova, Violet Kasabri, Randa Naffa, Reema Alquoqa
Diabetes and Metabolic Syndrome Clinical Research and Reviews, 2018
Glycated LDL-C and glycated HDL-C in association with adiposity, blood and atherogenicity indices in metabolic syndrome patients with and without prediabetes
Rawan Mohammad Al Saudi, Violet Kasabri, Randa Naffa, Nailya Bulatova, Yasser Bustanji
Therapeutic Advances in Endocrinology and Metabolism, 2018
Evaluation of four calcium channel blockers as fluconazole resistance inhibitors in Candida glabrata
Lina M. Alnajjar, Nailya R. Bulatova, Rula M. Darwish
Journal of Global Antimicrobial Resistance, 2018
Impact of home medication management review on medication adherence among Jordanian patients
Rajaa A. Al-Qudah, Nailya R. Bulatova, Nathir M. Obeidat, Iman A. Basheti
Journal of Pharmaceutical Health Services Research, 2018
Home medication management review in outpatients with alarming health issues in Jordan: a randomized control trial
Iman A. Basheti, Mai Rizik, Nailya R. Bulatova
Journal of Pharmaceutical Health Services Research, 2018
Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-naïve pre-diabetic and diabetic patients: A randomized controlled study
Nailya Bulatova, Violet Kasabri, Amenah Qotineh, Taiba AL-Athami, Al-Motassem Yousef, Salah AbuRuz, Munther Momani, Aymen Zayed
Diabetes and Metabolic Syndrome Clinical Research and Reviews, 2018
Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes
K. O. Tofiq, N. Bulatova, V. Kasabri, M. Suyagh, L. Halaseh, S. Alalawi
Bratislava Medical Journal, 2018
Association of oxytocin with glucose intolerance and inflammation biomarkers in metabolic syndrome patients with and without prediabetes
Amal Akour, Violet Kasabri, Nailya Bulatova, Suha Al Muhaissen, Randa Naffa, Hiba Fahmawi, Munther Momani, Ayman Zayed, Yasser Bustanji
Review of Diabetic Studies, 2017
Insulin resistance and levels of cardiovascular biomarkers in night-shift workers
Amal Akour, Rana Abu Farha, Eman Alefishat, Violet Kasabri, Nailya Bulatova, Randa Naffa
Sleep and Biological Rhythms, 2017
Levels of metabolic markers in drug-naive prediabetic and type 2 diabetic patients
Amal Akour, Violet Kasabri, Nailya Boulatova, Yasser Bustanji, Randa Naffa, Dana Hyasat, Nahla Khawaja, Haidar Bustanji, Ayman Zayed, Munther Momani
Acta Diabetologica, 2017
The correlation between plasma levels of oxytocin and betatrophin in non-diabetic and diabetic metabolic syndrome patients: A cross sectional study from Jordan
Amani Al-Rawashdeh, Violet Kasabri, Nailya Bulatova, Amal Akour, Ayman Zayed, Munther Momani, Nahla Khawaja, Haider Bustanji, Dana Hyasat
Diabetes and Metabolic Syndrome Clinical Research and Reviews, 2017
Evaluation of correlations of Plasma Levels of Oxytocin, Omentin-1 and Irisin in Diabetic and Non-Diabetic Metabolic Syndrome Patients: A Cross Sectional Study in Jordan
Jordan Medical Journal, 2017
Elevated serum levels of pro-inflammatory markers are associated with glucose intolerance in metabolic syndrome patients from Jordan
Amal A. Akour, Violet N. Kasabri, Nailya Y. Bulatova
Jordan Medical Journal, 2016
The use of medicinal herbs in gynecological and pregnancy-related disorders by Jordanian women: a review of folkloric practice vs. evidence-based pharmacology
Amal Akour, Violet Kasabri, Fatma U. Afifi, Nailya Bulatova
Pharmaceutical Biology, 2016
The use and safety of medications known to affect driving in Jordan: A cross-sectional study
Eman Elayeh, Nailya Bulatova, Iman Basheti, Rana Abu Farha, Naseer Al-Rawi, Ahmad Abu Snaineh, Ibrahim Alahwal
Traffic Injury Prevention, 2016
Home medication management review in outpatients with chronic diseases in Jordan: a randomized control trial
Iman A. Basheti, Rajaa A. Al-Qudah, Nathir M. Obeidat, Nailya R. Bulatova
International Journal of Clinical Pharmacy, 2016
Associations between patient factors and medication adherence: A Jordanian experience
Iman A. Basheti, Sami Saqf el Hait, Eyad A. Qunaibi, Salah Aburuz, Nailya Bulatova
Pharmacy Practice, 2016
Influence of genotype and haplotype of MDR1 (C3435T, G2677A/T, C1236T) on the incidence of breast cancer - a case-control study in Jordan
Ali M Abuhaliema, Al-Motassem F Yousef, Nirmeen N El-Madany, Nailya R Bulatova, Nemah M Awwad, Muhammad A Yousef, Khalil Z Al Majdalawi
Asian Pacific Journal of Cancer Prevention, 2016
Effects of genetic polymorphism in CYP3A4 and CYP3A5 genes on tacrolimus dose among kidney transplant recipients
Iranian Journal of Kidney Diseases, 2016
Lack of association between CYP1A1 M2 and M4 polymorphisms and breast carcinoma in Jordanian women: A case-control study
Iman Amrani, Nailya Bulatova, Abdalla Awidi, Al-Motassem Yousef, Jamal Masad Melhem, Mahmoud Al-Masri, Laila Abu Tahoun
Asian Pacific Journal of Cancer Prevention, 2016
Evaluation of the correlation of oxytocin plasma levels and metabolic syndrome biomarkers (Leptin, adiponectin and resistin) in newly diagnosed type 2 diabetes patients in Jordan: A cross sectional study
Mais M. AL-Nouaaimi, Violet Kasabri, Amal Akour
Jordan Journal of Pharmaceutical Sciences, 2016
Evaluation of oxytocin (OXT), endothelin-1 and nesfatin plasma concentrations in newly-diagnosed diabetic and non-diabetic patients with metabolic syndrome
Amal Abu Hanoud, Violet Kasabri, Naiyla Bulayova
Jordan Journal of Pharmaceutical Sciences, 2016
Knowledge, attitude and opinion of drug misuse and abuse by pharmacy students: A cross-sectional study in Jordan
D Jaber, N Bulatova, M Suyagh, A-M Yousef, M Wazaify
Tropical Journal of Pharmaceutical Research, 2015
Genotype and haplotype analysis of ABCB1 at 1236, 2677 and 3435 among jordanian population
O Al-Diab, A Yousef, E Al Manassrah, A Masadeh, M Olemat, H Qosa, A Kherbash, NR Bulatova
Tropical Journal of Pharmaceutical Research, 2015
Stroke awareness in the general population: A study from Jordan
SS Madae’en, NR Bulatova, A Al-Qhewii, LH Sakran, HH El-Zayyat, MKA Kamar, HS Al-Haqeesh, AM Younes
Tropical Journal of Pharmaceutical Research, 2013
Hypertension management and factors associated with blood pressure control in Jordanian patients attending cardiology clinic
NR Bulatova, AM Yousef, SD AbuRuz, RA Farha
Tropical Journal of Pharmaceutical Research, 2013
Effect of divergence in patients' socioeconomic background on their perspective of the role of the community pharmacist in Amman, Jordan
E Qunaibi, IA Basheti, E Qunaibi, IA Basheti, SA Hamadi, NR Bulatova, A Shanah, E Abu-Gharbieh
Tropical Journal of Pharmaceutical Research, 2013
Treatment related problems for outpatients with chronic diseases in Jordan: The value of home medication reviews
Iman A. Basheti, Eyad A. Qunaibi, Nailya R. Bulatova, Sundos Samara, Salah AbuRuz
International Journal of Clinical Pharmacy, 2013
Home medication reviews in a patient care experience for undergraduate pharmacy students
Iman A. Basheti, Eyad A. Qunaibi, Salah AbuRuz, Sundos Samara, Nailya R. Bulatova
American Journal of Pharmaceutical Education, 2013
Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population
Al-Motassem Yousef, Nailya R. Bulatova, William Newman, Nancy Hakooz, Said Ismail, Hisham Qusa, Farah Zahran, Nidaa Anwar Ababneh, Farah Hasan, Imad Zaloom, Ghada Khayat, Rawan Al-Zmili, Randa Naffa, Ola Al-Diab
Molecular Biology Reports, 2012
Expectations and experiences of physicians regarding pharmaceutical care and the expanding role of pharmacists in Jordan
Jordan Journal of Pharmaceutical Sciences, 2012
Management of hypertension and factors affecting its control in Jordanian renal transplant recipients
Nailya Bulatova, Al-Motassem Yousef, Hisham Qusa, Ghada Al Khayat, Wadad Ailabouni, Ayman Wahbeh, Muhammad Al-Ulemat
International Journal of Clinical Pharmacy, 2012
Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan
Salah M. AbuRuz, Nailya R. Bulatova, Al-Moatasem M. Yousef, Mutasim A. Al-Ghazawi, Izzat A. Alawwa, Akram Al-Saleh
International Journal of Clinical Pharmacy, 2011
Investigation of the impact of aeroallergens sensitization on allergic rhinitis severity
Jordan Medical Journal, 2011
Adverse effects of tacrolimus in renal transplant patients from living donors
Nailya Bulatova, Al-Motassem Yousef, Ghada Al-Khayyat, Hisham Qosa
Current Drug Safety, 2011
Skin prick test reactivity to aeroallergens in Jordanian allergic rhinitis patients
S. Aburuz, N. Bulatova, M. Tawalbeh
Eastern Mediterranean Health Journal, 2011
Current view on biology of aging
Jordan Medical Journal, 2010
Development and validation of the Arabic allergic rhinitis quality of life questionnaire
Saudi Medical Journal, 2009
The validity and reliability of the Arabic version of the EQ-5D: A study from Jordan
Salah Aburuz, Naela Bulatova, Mohammed Twalbeh, Moatasem Gazawi
Annals of Saudi Medicine, 2009
Recurrent ecchymoses after acute tacrolimus intoxication
Kamal F. Akl, Nailya Bulatova, Al-Motassem Yousef
Pediatric Nephrology, 2008
Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel
A.-M. Yousef, T. Arafat, N. R. Bulatova, R. Al-Zumyli
Journal of Clinical Pharmacy and Therapeutics, 2008
Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans
Nailya R. Bulatova, Rula M. Darwish
Medical Principles and Practice, 2008
Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitus
Nailya R. Bulatova, Al Motassem F. Yousef, Salah M. AbuRuz
Thrombosis Research, 2007
An innovative pharmaceutical care practical course
N. R. Bulatova, S. Aburuz, A. M. Yousef
Advances in Health Sciences Education, 2007
Validation of a comprehensive classification tool for treatment-related problems
Salah M. AbuRuz, Nailya R. Bulatova, Almoatasem M. Yousef
Pharmacy World and Science, 2006
Association of polycystic ovaries with the use of valproic acid in Jordanian epileptic patients
S Otoom, M Nusier, M Hasan, H Hadidi, R Samawi, A M Younes, M Darweesh, N R Boulatova
Clinical Drug Investigation, 2003
The association of polycystic ovaries with the use of valproate in epilepsy
European Journal of Clinical Pharmacology, 2001
Effect of tuftsin and oxymethacil on macrophagal tyrosine hydroxylase during chronic stress
M. F. Mineeva, N. R. Bulatova, A. V. Val'dman
Bulletin of Experimental Biology and Medicine, 1990
The effect of tuftsin and hydroxymethazyl on macrophage tyrosine hydroxylase activity in chronic stress
Byulleten Eksperimentalnoi Biologii I Meditsiny, 1990
Changes in synaptosomal membranes from cerebral cortex due to psychogenic stress in rats
Annali Dell Istituto Superiore Di Sanita, 1990
Immune modulating and antistress properties of oxymethacyl
D.N. Lazareva, G.A. Tolstikov, E.K. Alyokhin, V.V. Pletchov, S.K. Sarmanaev, N.R. Bulatova, A.V. Krinskaya, A.V. Val'dman, V.P. Krivonogov
European Journal of Pharmacology, 1990
Poststressor correction of macrophage function by tuftsin and its derivatives
N. R. Bulatova, E. A. Romanova, A. V. Krinskaya, E. I. Sarychev, A. V. Val'dman
Bulletin of Experimental Biology and Medicine, 1989
Poststressor correction of the macrophage functional activity by tuftsin and its derivatives
Byulleten Eksperimentalnoi Biologii I Meditsiny, 1989

Nailya Bulatova

EDUCATION

RESEARCH INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS